骨质疏松症患者口腔种植治疗的风险与对策  

Risks and countermeasures of dental implant treatment in osteoporosis patients

作　　者：柳忠豪[1,2] 董凯 Liu Zhonghao;Dong Kai(Department of Oral Implantology,Yantai Stomatological Hospital Affiliated to Binzhou Medical University,Yantai 264008,China;School of Stomatology,Binzhou Medical University,Yantai 264003,China)

机构地区：[1]滨州医学院附属烟台口腔医院口腔种植科,264008 [2]滨州医学院口腔医学院,烟台264003

出　　处：《中国口腔种植学杂志》2024年第4期303-310,共8页Chinese Journal of Oral Implantology

摘　　要：骨质疏松症是一种全身性骨骼疾病,以骨密度降低及骨量减少为主要特征。随着我国人口老龄化程度加剧,骨质疏松的发病率也逐年上升。作为牙缺失的首选治疗方法,种植牙具有很高的留存率,但对于骨质疏松患者,骨组织微结构的损坏可能会导致口腔种植治疗失败的风险增高。虽然骨质疏松不是口腔种植治疗的禁忌证,但是临床医生仍应高度重视相关风险因素。本文对骨质疏松患者的牙槽骨塑形及改建、种植牙留存率、抗骨质疏松药物的影响以及牙种植治疗策略这几方面进行探讨,以供临床参考。Osteoporosis(OP)is a systemic skeletal disease with the main characteristic of reduction of bone density and low bone mass.With the increasing age of the population,the incidence of OP increases year by year.Replacement of missing teeth with dental implants is one of the most common treatment options with a high success rate.However,in patients with OP,deterioration of bone tissue may lead to an increased risk of implant failure.Although OP is not a contraindication for implant therapy,clinicians should still pay great attention to associated risk factors.This article discusses the alveolar bone modeling and remodeling,the success rates of dental implants,the influence of antiosteoporosis drugs,and the strategy of dental implant treatment in OP patients for clinical reference.

关 键 词：骨质疏松症 牙种植 骨结合 边缘骨吸收 

分 类 号：R783.6[医药卫生—口腔医学] R580[医药卫生—临床医学]